Funded Tech Companies

EVS Glaucoma Therapeutics

Headquartered in Herndon, EVS Glaucoma Therapeutics raised its funding from CIT GAP Fund.

Company Overview

Company Name
EVS Glaucoma Therapeutics
Company Status
Private & Independent
Funding Rounds
Total Funding

Contact Information

Mailing Address
2776 Towerview Rd.
Herndon, VA 20171
USA
Phone
Undisclosed
Website
Email Address
Not Recorded

Company Background Information

Overview
EVS Glaucoma Therapeutics, a Herndon-based spinout of Euclid Vision Systems that develops a sustained delivery system for glaucoma medication. EGT develops an implantable, bio-degradable, collagen-based drug delivery system for Latanoprost, the leading prescribed glaucoma medication.
Profile
EVS Glaucoma Therapeutics LinkedIn Company Profile
Social Media
EVS Glaucoma Therapeutics Company Twitter Account
Company News
EVS Glaucoma Therapeutics News
Facebook
EVS Glaucoma Therapeutics on Facebook
YouTube
EVS Glaucoma Therapeutics on YouTube
Last Transaction
9/12/2013

Financing History

Date
Type
Amount
Venture Equity
Unknown


Management Team

Title
Name
Email & Social
Chief Executive Officer
Michael Ross
  Michael Ross LinkedIn Profile  Michael Ross Twitter Account  Michael Ross News  Michael Ross on Facebook


Company Investors

  • CIT GAP Fund

 

 

 

Browse more funded tech companies:

Evrything | Evtron

 

Share this article

 


About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary